$57.75
-0.88 (-1.50%)
Quest Diagnostics, Inc. (DGX)
CAPS Rating:
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

RSS Headlines
Fool UK
Recs
leading provider of independent diagnostic testing
This stock is going to go alot higher because of their large ownership in VRML, which is heavly into Ovarian Cancer Research. They were approved for a patent for their studies. More information can be found at investorvillage.com under board name VRML